Prognostic and predictive factors in patients with metastatic or recurrent cervical cancer treated with platinum-based chemotherapy.

BACKGROUND: Recognizing resistance or susceptibility to the current standard cisplatin and paclitaxel treatment could improve therapeutic outcomes of metastatic or recurrent cervical cancer. METHODS: Forty-five tissue samples from patients participating in a phase II trial of cisplatin and ifosfamid...

Descripción completa

Detalles Bibliográficos
Autores principales: Karageorgopoulou, Sofia, Kostakis, Ioannis D., Gazouli, Maria, Markaki, Sonia, Papadimitriou, Marios, Bournakis, Evangelos, Dimopoulos, Meletios-Athanassios, Papadimitriou, Christos A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5490227/
https://www.ncbi.nlm.nih.gov/pubmed/28659181
http://dx.doi.org/10.1186/s12885-017-3435-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5490227/
https://www.ncbi.nlm.nih.gov/pubmed/28659181
http://dx.doi.org/10.1186/s12885-017-3435-x

Ejemplares similares